111 related articles for article (PubMed ID: 7896438)
1. Clinical characteristics of metachronous colorectal tumors.
Rennert G; Robinson E; Rennert HS; Neugut AI
Int J Cancer; 1995 Mar; 60(6):743-7. PubMed ID: 7896438
[TBL] [Abstract][Full Text] [Related]
2. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
Suthananthan AE; Bhandari M; Platell C
ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
[TBL] [Abstract][Full Text] [Related]
3. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
[TBL] [Abstract][Full Text] [Related]
4. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
[TBL] [Abstract][Full Text] [Related]
5. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
6. Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance.
Lan YT; Lin JK; Li AF; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Chang SC
Int J Colorectal Dis; 2005 Mar; 20(2):121-5. PubMed ID: 15349739
[TBL] [Abstract][Full Text] [Related]
7. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
[TBL] [Abstract][Full Text] [Related]
8. Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancer.
Razenberg LG; Creemers GJ; Beerepoot LV; Vos AH; van de Wouw AJ; Maas HA; Lemmens VE
Acta Oncol; 2016 Dec; 55(12):1443-1449. PubMed ID: 27585122
[TBL] [Abstract][Full Text] [Related]
9. Survival in patients with metachronous second primary lung cancer.
Ha D; Choi H; Chevalier C; Zell K; Wang XF; Mazzone PJ
Ann Am Thorac Soc; 2015 Jan; 12(1):79-84. PubMed ID: 25494009
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and survival of patients with multiple metachronous esophageal tumor.
Mukhtar F; Bubu OM; Hung N L
Cancer Treat Res Commun; 2018; 17():13-17. PubMed ID: 30173004
[TBL] [Abstract][Full Text] [Related]
11. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
Mulder SA; Kranse R; Damhuis RA; Ouwendijk RJ; Kuipers EJ; van Leerdam ME
Dis Colon Rectum; 2012 May; 55(5):522-31. PubMed ID: 22513430
[TBL] [Abstract][Full Text] [Related]
12. Survival in colorectal carcinoma associated with previous extracolonic cancer.
Varty PP; Delrio P; Boulos PB
Ann R Coll Surg Engl; 1994 May; 76(3):180-4. PubMed ID: 8017812
[TBL] [Abstract][Full Text] [Related]
13. TNM stage is the most important determinant of survival in metachronous lung cancer.
Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice.
Razenberg LG; van Gestel YR; de Hingh IH; Loosveld OJ; Vreugdenhil G; Beerepoot LV; Creemers GJ; Lemmens VE
BMC Cancer; 2016 Feb; 16():110. PubMed ID: 26882902
[TBL] [Abstract][Full Text] [Related]
15. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study.
Gervaz P; Bucher P; Neyroud-Caspar I; Soravia C; Morel P
Dis Colon Rectum; 2005 Feb; 48(2):227-32. PubMed ID: 15711864
[TBL] [Abstract][Full Text] [Related]
16. Cumulative incidence of metachronous colorectal cancer.
Cali RL; Pitsch RM; Thorson AG; Watson P; Tapia P; Blatchford GJ; Christensen MA
Dis Colon Rectum; 1993 Apr; 36(4):388-93. PubMed ID: 8458267
[TBL] [Abstract][Full Text] [Related]
17. Metachronous colorectal cancer: a competing risks analysis with consideration for a stratified approach to surveillance colonoscopy.
Battersby NJ; Coupland A; Bouliotis G; Mirza N; Williams JG
J Surg Oncol; 2014 Apr; 109(5):445-50. PubMed ID: 24272767
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
19. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
[TBL] [Abstract][Full Text] [Related]
20. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
Bova R; Kamphues C; Neuhaus P; Puhl G
Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
